| Primary |
| Delirium |
42.9% |
| Product Used For Unknown Indication |
28.6% |
| Gastritis |
9.5% |
| Parkinsonism |
9.5% |
| Hypertension |
4.8% |
| Major Depression |
4.8% |
|
| Restless Legs Syndrome |
50.0% |
| Delirium |
25.0% |
| Hypotension |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
21.6% |
| Schizophrenia |
15.8% |
| Schizophrenia, Paranoid Type |
12.9% |
| Bipolar Disorder |
6.4% |
| Parkinson's Disease |
5.8% |
| Akathisia |
4.7% |
| Acute Psychosis |
4.1% |
| Major Depression |
4.1% |
| Dystonia |
3.5% |
| Intentional Overdose |
3.5% |
| Depression |
2.9% |
| Dyskinesia |
2.3% |
| Tremor |
2.3% |
| Anxiety |
1.8% |
| Psychotic Disorder |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Aggression |
1.2% |
| Anorexia Nervosa |
1.2% |
| Bipolar I Disorder |
1.2% |
| Extrapyramidal Disorder |
1.2% |
|
| Tremor |
12.8% |
| Colitis Ischaemic |
10.3% |
| Dystonia |
10.3% |
| Neuroleptic Malignant Syndrome |
7.7% |
| Deep Vein Thrombosis |
5.1% |
| Intentional Overdose |
5.1% |
| Psychotic Disorder |
5.1% |
| Rhabdomyolysis |
5.1% |
| Speech Disorder |
5.1% |
| Suicidal Ideation |
5.1% |
| Suicide Attempt |
5.1% |
| Drug Ineffective |
2.6% |
| Hypothermia |
2.6% |
| Ileus |
2.6% |
| Metabolic Encephalopathy |
2.6% |
| Parkinsonism |
2.6% |
| Poisoning |
2.6% |
| Prescribed Overdose |
2.6% |
| Rectal Haemorrhage |
2.6% |
| Stupor |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Schizophrenia |
15.5% |
| Bipolar Disorder |
14.2% |
| Depression |
7.3% |
| Bipolar I Disorder |
5.7% |
| Extrapyramidal Disorder |
4.4% |
| Psychotic Disorder |
4.4% |
| Hypomania |
4.1% |
| Personality Disorder |
4.1% |
| Major Depression |
2.8% |
| Parkinson's Disease |
2.3% |
| Schizophrenia, Paranoid Type |
2.3% |
| Oculogyric Crisis |
2.1% |
| Anxiety |
1.8% |
| Diabetes Mellitus |
1.3% |
| Parkinsonism |
1.3% |
| Agitation |
1.0% |
| Choreoathetosis |
1.0% |
| Hiv Infection |
1.0% |
| Hyperlipidaemia |
1.0% |
|
| Schizophrenia |
11.1% |
| Neuroleptic Malignant Syndrome |
9.3% |
| Liver Disorder |
5.6% |
| Neurodegenerative Disorder |
5.6% |
| Rhabdomyolysis |
5.6% |
| Suicidal Ideation |
5.6% |
| Thinking Abnormal |
5.6% |
| Tremor |
5.6% |
| Weight Decreased |
5.6% |
| Diabetes Mellitus |
3.7% |
| Disorientation |
3.7% |
| Hyperammonaemic Encephalopathy |
3.7% |
| Renal Failure |
3.7% |
| Salivary Hypersecretion |
3.7% |
| Sleep-related Eating Disorder |
3.7% |
| Tachycardia |
3.7% |
| Tardive Dyskinesia |
3.7% |
| Thirst Decreased |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Type 1 Diabetes Mellitus |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
44.0% |
| Bipolar Disorder |
24.0% |
| Aggression |
20.0% |
| Depression |
12.0% |
|
| Neuroleptic Malignant Syndrome |
50.0% |
| Rhabdomyolysis |
50.0% |
|
